Age, high stress levels, and poor nutrition can all cause our internal levels to dip
This broad applicability makes it particularly interesting for complex ankle injuries that often involve damage to multiple structures
Here, we provide the first evidence of improved healthspan and age-related survival with a therapeutic mAb by demonstrating that treatment with an IGF-1R antagonist in older mice significantly and preferentially improves several indices of healthspan, reduced death from neoplastic disease, and increased mean and median lifespan in females
Because mobile IV therapy costs more per visit than in-clinic care, frequent use can add up quickly
This method is more effective than oral supplements for people with absorption issues
Perioperative Outcomes and Downstaging Following Neoadjuvant Therapy For Lung Cancer - Analysis of the National Cancer Database